Skip to content
CONTACT
Contact Us
Office Locations
CAREERS
IMPORTANT NOTICE – METFORMIN
Search for:
ABOUT US
About Us
Corporate Overview
Major Milestones
Leadership
Code of Conduct
Compliance & Ethics Program
SPECIALTY
Specialty
Specialty Strategy
Branded Products
Business Development
GENERICS
Generics
Products
MEDICAL AFFAIRS
Medical Affairs
United States Medical Affairs
Global Clinical Development and Clinical Operations
PRODUCT DEVELOPMENT
Product Development
Inhalation Research
Microsieve Technology
LIFE AT LUPIN
Why Lupin?
Lupin U.S. Locations
Current Openings
RESOURCES
Return Goods Policy
Globe
AUSTRALIA
BRAZIL
CANADA
GERMANY
INDIA
MEXICO
PHILIPPINES
RUSSIA
SOUTH AFRICA
SWITZERLAND
NETHERLANDS
USA
Leadership
Lupin Pharmaceuticals
2020-07-21T19:00:30+05:30
Leadership
ABOUT US
CORPORATE OVERVIEW
LEADERSHIP
MAJOR MILESTONES
CODE OF CONDUCT
COMPLIANCE & ETHICS PROGRAM
LUPIN U.S. LEADERSHIP
Deep industry experience and a heritage of innovation define Lupin’s U.S. leadership.
Vinita Gupta
CEO
Alok Sonig
CEO – US Generics,
Head Global R&D and Biosimilars
Jon Stelzmiller
President – Head of US Specialty Business
Alan Butcher
Chief Corporate Development Officer
Dr. Sofia Mumtaz
President, Pipeline Management and Legal
Bob Hoffman
Executive Vice President of Generics
Xian-Ming Zeng, PhD
Executive Vice President, Head of
Inhalation and Complex Injectables
Sean Moriarty
Senior Vice President of
Legal – Americas and EMEA
Lisa Middlebrook
Senior Vice President of
Human Resources – Americas
Dave Berthold
Senior Vice President of Generics
Gregory Kaufman, MD
Senior Vice President, Global Clinical
and Medical Affairs – Specialty
Kalpana Vanam
Senior Vice President of
Regulatory Affairs
Minaksi Bhatt
Senior Vice President, Global Intellectual Property